The Benefits of Family Screening in Rare Diseases: Genetic Testing Reveals 165 New Cases of Fabry Disease among At-Risk Family Members of 83 Index Patients
Background: Fabry disease (FD, OMIM #301500) is a rare, progressive, X-linked, inherited genetic disease caused by a functional deficiency of lysosomal α-galactosidase, leading to the accumulation of glycosphingolipids in virtually all of the body’s cell types and fluids. Patients with rare genetic...
Main Authors: | Sergey Moiseev, Ekaterina Tao, Alexey Moiseev, Nikolay Bulanov, Ekaterina Filatova, Victor Fomin, Dominique P. Germain |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/9/1619 |
Similar Items
-
Cornea verticillata in Fabry disease
by: S V Moiseev, et al.
Published: (2018-12-01) -
Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease
by: V. I. Ignatyeva, et al.
Published: (2019-01-01) -
Morphological verification of renal lesion as a compulsory stage in the diagnosis of Fabry disease
by: P V Glybochko, et al.
Published: (2014-12-01) -
Fabry disease – what a gastroenterologist should know
by: Alicja Rydzewska-Rosołowska, et al.
Published: (2023-12-01) -
Brazilian consensus recommendations for the diagnosis, screening, and treatment of individuals with fabry disease: Committee for Rare Diseases - Brazilian Society of Nephrology/2021
by: Cassiano Augusto Braga Silva, et al.
Published: (2022-02-01)